Shanghai Labway Clinical Laboratory Co Ltd (301060) — Capital Reinvestment Ratio
Shanghai Labway Clinical Laboratory Co Ltd (301060) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥135.78 Million) in capital expenditures (CN¥13.41 Million). Check tangible net worth ratio of Shanghai Labway Clinical Laboratory Co L to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Labway Clinical Laboratory Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Shanghai Labway Clinical Laboratory Co Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see 301060 cash generation efficiency.
Annual Capital Reinvestment Ratio for Shanghai Labway Clinical Laboratory Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2025. See Shanghai Labway Clinical Laboratory Co L free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥268.85 Million | CN¥58.49 Million | ▼ -38.6% |
| 2024 | 0.35x | CN¥216.31 Million | CN¥76.62 Million | ▼ -51.4% |
| 2023 | 0.73x | CN¥546.99 Million | CN¥398.89 Million | ▼ -73.3% |
| 2022 | 2.73x | CN¥84.17 Million | CN¥230.08 Million | ▲ +413.9% |
| 2021 | 0.53x | CN¥223.51 Million | CN¥118.88 Million | ▲ +100.4% |
| 2020 | 0.27x | CN¥167.87 Million | CN¥44.55 Million | ▼ -52.6% |
| 2019 | 0.56x | CN¥70.60 Million | CN¥39.51 Million | ▲ +41.0% |
| 2018 | 0.40x | CN¥184.79 Million | CN¥73.34 Million | ▼ -89.6% |
| 2016 | 3.80x | CN¥27.14 Million | CN¥103.24 Million | ▲ +614.4% |
| 2015 | 0.53x | CN¥79.70 Million | CN¥42.45 Million | ▼ -94.6% |
| 2013 | 9.90x | CN¥1.63 Million | CN¥16.13 Million | — |